PS Channel

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
BMY Description — Bristol-Myers Squibb Co.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co. has products in the following therapeutic classes: oncology; cardiovascular; immunoscience; and virology, including human immunodeficiency virus (HIV) infection. Co.'s products include: Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B; and Reyataz is a protease inhibitor for the treatment of HIV.

Company Name: Bristol-Myers Squibb Co.
Sector: Drugs & Pharmaceuticals
Number of ETFs Holding BMY: 107
Total Market Value Held by ETFs: $9,408,102,071
Total Market Capitalization: $102,507,000,000
% of Market Cap. Held by ETFs: 9.18%
ETF BMY Weight BMY Amount
VTI 0.38% $2,466,252,079
VOO 0.45% $1,748,881,381
SPY 0.43% $1,221,709,894
VUG 0.93% $689,189,862
IVV 0.45% $672,458,098
XLV 3.09% $515,634,983
VYM 1.03% $298,014,545
VHT 2.76% $227,377,241
IWD 0.42% $157,771,284
IWF 0.39% $153,358,774
List of all 107 ETFs holding BMY ยป
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
25 Dividend Giants Widely Held By ETFs
25 S.A.F.E. Dividend Stocks Increasing Payments For Decades
Broker Darlings: Top 15 Analyst Picks of the Dow
Top 25 Broker Analyst Picks of the S&P 500
Forgotten S&P 500 Giants: Analysts' Current Least Favorites
25 Top Ranked Socially Responsible Dividend Stocks
10 Oversold ETFs

10 ETFs Crossing Above Their 200 DMA
The 10 Biggest ETFs
The 10 Best ETF Performers
The 10 Worst ETF Performers
10 ETFs With Notable Inflows
10 ETFs With Notable Outflows
Top 10 Analyst Rated Consumer Stocks
Top 10 Analyst Rated Healthcare Stocks
Top 10 Analyst Rated Technology Stocks

Quotes delayed 20 minutes

Buy (2.75 out of 4)
28th percentile
(ranked lower than approx. 72% of all stocks covered)

Analysts Forecast:
BMY Price Target

Based on


Fri, Feb 9, 10:00 AM, Zacks

Although pharma ETFs saw terrible trading over the past one month in the latest global market rout, the string of earnings beat bolstered confidence in the space.

Wed, Feb 7, 9:59 AM, Zacks

Seattle Genetics (SGEN) beats estimates on both counts on the back of strong Adcetris sales.

Top Finances News

wells fargo bank stock symbol msci hong kong small cap index latest news acad pharma stock campbell soup stock price history wells fargo advantage income opportunities fund brk b stock price split dalton funeral home new hyde park vanguard msci emerging markets etf john hancock capital appreciation fund how to buy brk b shares price of bank of america time warner cable ticker symbol

ETFs Holding BMY | Bristol-Myers Squibb Co. | PC Channel | | Copyright © 2009 - 2018, All Rights Reserved

Nothing in PC Channel is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following and . and ETF videos powered by . Quote data delayed at least 20 minutes; , and . ; .